DERMAPHARM HOLDING SE (DMP.DE) Stock Fundamental Analysis
FRA:DMP - Deutsche Boerse Ag - DE000A2GS5D8 - Common Stock - Currency: EUR
We assign a fundamental rating of 5 out of 10 to DMP. DMP was compared to 53 industry peers in the Pharmaceuticals industry. DMP has a medium profitability rating, but doesn't score so well on its financial health evaluation. DMP has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year DMP was profitable.
In the past year DMP had a positive cash flow from operations.
In the past 5 years DMP has always been profitable.
In the past 5 years DMP always reported a positive cash flow from operatings.
1.2 Ratios
DMP's Return On Assets of 4.90% is in line compared to the rest of the industry. DMP outperforms 47.17% of its industry peers.
DMP has a Return On Equity of 16.22%. This is in the better half of the industry: DMP outperforms 66.04% of its industry peers.
DMP's Return On Invested Capital of 7.14% is in line compared to the rest of the industry. DMP outperforms 45.28% of its industry peers.
The Average Return On Invested Capital over the past 3 years for DMP is below the industry average of 14.71%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.9% | ||
| ROE | 16.22% | ||
| ROIC | 7.14% |
ROA(3y)5.95%
ROA(5y)7.95%
ROE(3y)18.55%
ROE(5y)24.89%
ROIC(3y)9.78%
ROIC(5y)10.35%
1.3 Margins
DMP's Profit Margin of 8.74% is in line compared to the rest of the industry. DMP outperforms 41.51% of its industry peers.
DMP's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 17.82%, DMP perfoms like the industry average, outperforming 50.94% of the companies in the same industry.
In the last couple of years the Operating Margin of DMP has grown nicely.
The Gross Margin of DMP (64.76%) is worse than 60.38% of its industry peers.
DMP's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.82% | ||
| PM (TTM) | 8.74% | ||
| GM | 64.76% |
OM growth 3Y-14.93%
OM growth 5Y2.07%
PM growth 3Y-24.31%
PM growth 5Y-2.64%
GM growth 3Y-0.44%
GM growth 5Y3.48%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so DMP is still creating some value.
DMP has about the same amout of shares outstanding than it did 1 year ago.
DMP has about the same amout of shares outstanding than it did 5 years ago.
DMP has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.15 indicates that DMP is not a great score, but indicates only limited risk for bankruptcy at the moment.
DMP has a Altman-Z score (2.15) which is comparable to the rest of the industry.
DMP has a debt to FCF ratio of 7.58. This is a slightly negative value and a sign of low solvency as DMP would need 7.58 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.58, DMP is doing worse than 60.38% of the companies in the same industry.
DMP has a Debt/Equity ratio of 1.43. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.43, DMP is not doing good in the industry: 73.58% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.43 | ||
| Debt/FCF | 7.58 | ||
| Altman-Z | 2.15 |
ROIC/WACC1.2
WACC5.97%
2.3 Liquidity
A Current Ratio of 2.05 indicates that DMP has no problem at all paying its short term obligations.
DMP's Current ratio of 2.05 is fine compared to the rest of the industry. DMP outperforms 77.36% of its industry peers.
A Quick Ratio of 0.91 indicates that DMP may have some problems paying its short term obligations.
DMP has a Quick ratio (0.91) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.05 | ||
| Quick Ratio | 0.91 |
3. Growth
3.1 Past
DMP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 83.06%, which is quite impressive.
Measured over the past years, DMP shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.07% on average per year.
Looking at the last year, DMP shows a small growth in Revenue. The Revenue has grown by 6.24% in the last year.
Measured over the past years, DMP shows a quite strong growth in Revenue. The Revenue has been growing by 11.00% on average per year.
EPS 1Y (TTM)83.06%
EPS 3Y-18.42%
EPS 5Y8.07%
EPS Q2Q%-23.48%
Revenue 1Y (TTM)6.24%
Revenue growth 3Y7.79%
Revenue growth 5Y11%
Sales Q2Q%1.24%
3.2 Future
DMP is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.11% yearly.
Based on estimates for the next years, DMP will show a small growth in Revenue. The Revenue will grow by 2.63% on average per year.
EPS Next Y14.57%
EPS Next 2Y12.79%
EPS Next 3Y12.29%
EPS Next 5Y13.11%
Revenue Next Year0.58%
Revenue Next 2Y2.35%
Revenue Next 3Y2.31%
Revenue Next 5Y2.63%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 17.42 indicates a rather expensive valuation of DMP.
DMP's Price/Earnings is on the same level as the industry average.
DMP is valuated rather cheaply when we compare the Price/Earnings ratio to 27.25, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 12.86 indicates a correct valuation of DMP.
64.15% of the companies in the same industry are more expensive than DMP, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.80, DMP is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.42 | ||
| Fwd PE | 12.86 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, DMP is valued a bit cheaper than the industry average as 67.92% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DMP indicates a somewhat cheap valuation: DMP is cheaper than 73.58% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.72 | ||
| EV/EBITDA | 9.11 |
4.3 Compensation for Growth
DMP's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as DMP's earnings are expected to grow with 12.29% in the coming years.
PEG (NY)1.2
PEG (5Y)2.16
EPS Next 2Y12.79%
EPS Next 3Y12.29%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.55%, DMP has a reasonable but not impressive dividend return.
DMP's Dividend Yield is a higher than the industry average which is at 3.03.
Compared to an average S&P500 Dividend Yield of 2.34, DMP has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.55% |
5.2 History
The dividend of DMP has a limited annual growth rate of 2.71%.
Dividend Growth(5Y)2.71%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
DMP pays out 45.74% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of DMP is growing, but earnings are growing more, so the dividend growth is sustainable.
DP45.74%
EPS Next 2Y12.79%
EPS Next 3Y12.29%
FRA:DMP (7/31/2025, 5:29:23 PM)
33.45
-0.75 (-2.19%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners14.73%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.80B
Analysts80
Price Target46.31 (38.45%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.55% |
Yearly Dividend0.88
Dividend Growth(5Y)2.71%
DP45.74%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-2.37%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.42 | ||
| Fwd PE | 12.86 | ||
| P/S | 1.52 | ||
| P/FCF | 13.72 | ||
| P/OCF | 10.44 | ||
| P/B | 2.82 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.11 |
EPS(TTM)1.92
EY5.74%
EPS(NY)2.6
Fwd EY7.78%
FCF(TTM)2.44
FCFY7.29%
OCF(TTM)3.2
OCFY9.58%
SpS22
BVpS11.86
TBVpS-8.21
PEG (NY)1.2
PEG (5Y)2.16
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.9% | ||
| ROE | 16.22% | ||
| ROCE | 11.69% | ||
| ROIC | 7.14% | ||
| ROICexc | 7.64% | ||
| ROICexgc | 21.24% | ||
| OM | 17.82% | ||
| PM (TTM) | 8.74% | ||
| GM | 64.76% | ||
| FCFM | 11.08% |
ROA(3y)5.95%
ROA(5y)7.95%
ROE(3y)18.55%
ROE(5y)24.89%
ROIC(3y)9.78%
ROIC(5y)10.35%
ROICexc(3y)10.97%
ROICexc(5y)11.73%
ROICexgc(3y)29.64%
ROICexgc(5y)29.05%
ROCE(3y)16.03%
ROCE(5y)16.96%
ROICexcg growth 3Y-9.69%
ROICexcg growth 5Y2.94%
ROICexc growth 3Y-20.13%
ROICexc growth 5Y-1%
OM growth 3Y-14.93%
OM growth 5Y2.07%
PM growth 3Y-24.31%
PM growth 5Y-2.64%
GM growth 3Y-0.44%
GM growth 5Y3.48%
F-Score7
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.43 | ||
| Debt/FCF | 7.58 | ||
| Debt/EBITDA | 3.07 | ||
| Cap/Depr | 47.38% | ||
| Cap/Sales | 3.48% | ||
| Interest Coverage | 3.84 | ||
| Cash Conversion | 57.88% | ||
| Profit Quality | 126.76% | ||
| Current Ratio | 2.05 | ||
| Quick Ratio | 0.91 | ||
| Altman-Z | 2.15 |
F-Score7
WACC5.97%
ROIC/WACC1.2
Cap/Depr(3y)41.99%
Cap/Depr(5y)70.86%
Cap/Sales(3y)3.57%
Cap/Sales(5y)4.47%
Profit Quality(3y)204.39%
Profit Quality(5y)161.92%
High Growth Momentum
Growth
EPS 1Y (TTM)83.06%
EPS 3Y-18.42%
EPS 5Y8.07%
EPS Q2Q%-23.48%
EPS Next Y14.57%
EPS Next 2Y12.79%
EPS Next 3Y12.29%
EPS Next 5Y13.11%
Revenue 1Y (TTM)6.24%
Revenue growth 3Y7.79%
Revenue growth 5Y11%
Sales Q2Q%1.24%
Revenue Next Year0.58%
Revenue Next 2Y2.35%
Revenue Next 3Y2.31%
Revenue Next 5Y2.63%
EBIT growth 1Y28.45%
EBIT growth 3Y-8.31%
EBIT growth 5Y13.3%
EBIT Next Year57.91%
EBIT Next 3Y19.98%
EBIT Next 5Y6.79%
FCF growth 1Y-54.33%
FCF growth 3Y-4.81%
FCF growth 5Y24.67%
OCF growth 1Y-46.56%
OCF growth 3Y-7%
OCF growth 5Y14.89%